IndiaTickerLatest filing: Reply to Clarification- Financial results - Bal Pharma Limited
ObservedCompany dossier
Bal Pharma
NSE:BALPHARMA · ISIN INE083D01012
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Bal Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹73.2 Cr · PAT ₹0.5 Cr.
Exchange XBRLLatest ownership: promoter group 50.86% and public 49.14% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Reply to Clarification- Financial results - Bal Pharma Limited
NSE · financial results
Observed
Source filing Bal Pharma Ltd - 524824 - Intimation Regarding Corrigendum To The Postal Ballot Notice
BSE · exchange filing
Observed
Source filing Corrigendum - Bal Pharma Limited
NSE · exchange filing
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Bal Pharma Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹73.2 Cr
- Profit after tax
- ₹0.5 Cr
- EPS
- ₹0.33
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 50.86%
- Public
- 49.14%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL